
TOKYO -- Japanese drugmakers are joining forces with information technology companies and research institutions to create a government-backed consortium aimed at using artificial intelligence to discover new drugs more efficiently.
TOKYO -- Japanese drugmakers are joining forces with information technology companies and research institutions to create a government-backed consortium aimed at using artificial intelligence to discover new drugs more efficiently.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.